Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab.
about
Predictive value of quantitative HER2, HER3 and p95HER2 levels in HER2-positive advanced breast cancer patients treated with lapatinib following progression on trastuzumab.Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer
P2860
Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Role of HER2-Related Biomarker ...... cer Refractory to Trastuzumab.
@en
Role of HER2-Related Biomarker ...... cer Refractory to Trastuzumab.
@nl
type
label
Role of HER2-Related Biomarker ...... cer Refractory to Trastuzumab.
@en
Role of HER2-Related Biomarker ...... cer Refractory to Trastuzumab.
@nl
prefLabel
Role of HER2-Related Biomarker ...... cer Refractory to Trastuzumab.
@en
Role of HER2-Related Biomarker ...... cer Refractory to Trastuzumab.
@nl
P2093
P2860
P356
P1433
P1476
Role of HER2-Related Biomarker ...... cer Refractory to Trastuzumab.
@en
P2093
Hidekazu Todoroki
Kaname Kurashita
Kazuhisa Katayama
Kazuo Shimada
Kazuo Tamura
Maki Tanaka
Megumi Teraoka
Michiyo Saimura
Nobuyuki Arima
Reiki Nishimura
P2860
P356
10.1159/000468521
P50
P577
2017-05-06T00:00:00Z